How to use the speech recognition tool?
Clinical implication of Retinitis Pigmentosa molecular diagnostic using high throughput sequencing (RP-SEQ-HD)
Clinical implication of Retinitis Pigmentosa molecular diagnostic using high throughput sequencing (RP-SEQ-HD).
Status of the trial: Unknown
Orphan Drug Recognition: NA
- Opening Date: 2015-09-01
- Closing Date: 2018-09-30
Inclusion: Retinopathy pigmentosa without molecular diagnosis
Exclusion: Retinopathy pigmentosa with molecular diagnosis
Funder Type: national institution
Principal location of the trial
HCP: Principal investigators
Within ERN-EYE members
- Retinal Rare Eye Diseases (WG1)
This ERN is supported by: